AU4215499A - Treatment of neurodegenerative diseases - Google Patents

Treatment of neurodegenerative diseases

Info

Publication number
AU4215499A
AU4215499A AU42154/99A AU4215499A AU4215499A AU 4215499 A AU4215499 A AU 4215499A AU 42154/99 A AU42154/99 A AU 42154/99A AU 4215499 A AU4215499 A AU 4215499A AU 4215499 A AU4215499 A AU 4215499A
Authority
AU
Australia
Prior art keywords
treatment
neurodegenerative diseases
neurodegenerative
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU42154/99A
Other languages
English (en)
Inventor
David A. Brown
Wu Yun Ren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Codon Pharmaceuticals Inc
Original Assignee
Codon Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Codon Pharmaceuticals Inc filed Critical Codon Pharmaceuticals Inc
Publication of AU4215499A publication Critical patent/AU4215499A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU42154/99A 1998-05-28 1999-05-28 Treatment of neurodegenerative diseases Abandoned AU4215499A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8620098A 1998-05-28 1998-05-28
US09/086200 1998-05-28
PCT/US1999/011840 WO2002051395A1 (fr) 1998-05-28 1999-05-28 Traitement de maladies neurodegeneratives

Publications (1)

Publication Number Publication Date
AU4215499A true AU4215499A (en) 2002-07-08

Family

ID=22196952

Family Applications (1)

Application Number Title Priority Date Filing Date
AU42154/99A Abandoned AU4215499A (en) 1998-05-28 1999-05-28 Treatment of neurodegenerative diseases

Country Status (2)

Country Link
AU (1) AU4215499A (fr)
WO (1) WO2002051395A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005047492A1 (fr) * 2003-11-14 2005-05-26 Olsson Mats J Melanocytes utilises dans le traitement de maladies neurodegeneratives
ES2574557T3 (es) * 2004-09-21 2016-06-20 Btg International Limited Miméticos dopaminérgicos
EP2323640A2 (fr) * 2008-08-04 2011-05-25 Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. Procédés et compositions de traitement d'un dommage neuronal et de modulation de canaux potentiels de récepteurs transitoires
US8853189B2 (en) * 2012-05-31 2014-10-07 Prima Innovations, Llc Antispasmodic 1,2-Diols and 1,2,3-triols
JP6200527B2 (ja) 2013-03-12 2017-09-20 バイオ−ファーム ソリューションズ カンパニー リミテッド 神経保護用フェニルカルバメート化合物及びこれを含む組成物
JP6062077B2 (ja) 2013-03-12 2017-01-18 バイオ−ファーム ソリューションズ カンパニー リミテッド 小児てんかん及びてんかん関連症侯群の予防又は治療用フェニルカルバメート化合物｛ｐｈｅｎｙｌｃａｒｂａｍａｔｅｃｏｍｐｏｕｎｄｓｆｏｒｕｓｅｉｎｐｒｅｖｅｎｔｉｎｇｏｒｔｒｅａｔｉｎｇｐｅｄｉａｔｒｉｃｅｐｉｌｅｓｙａｎｄｅｐｉｌｅｓｙ−ｒｅｌａｔｅｄｓｙｎｄｒｏｍｅｓ｝
CN113559097A (zh) * 2015-06-10 2021-10-29 江苏先声药业有限公司 一种组合物在制备治疗肌萎缩性侧索硬化症药物中的应用
US10765642B2 (en) * 2015-09-09 2020-09-08 Korea Research Institute Of Bioscience And Biotechnology Composition for preventing or treating muscle weakness-related diseases comprising sobrerol
GB201912490D0 (en) * 2019-08-30 2019-10-16 Univ Greenwich Treatment of obesity and related conditions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352440A (en) * 1988-03-30 1994-10-04 Trustees Of Boston University Methods for increasing melanin content in melanocytes using diacylglycerols and uses thereof
US5210076A (en) * 1988-09-13 1993-05-11 Berliner David L Methods of treating Parkinson's disease using melanin
US5554359A (en) * 1989-12-15 1996-09-10 The Board Of Regents Of The University Of Oklahoma Pigmentation enhancer and method
US5470577A (en) * 1993-07-07 1995-11-28 Trustees Of Boston University Stimulation of tanning by DNA fragments or single-stranded DNA

Also Published As

Publication number Publication date
WO2002051395A1 (fr) 2002-07-04

Similar Documents

Publication Publication Date Title
AU3673499A (en) Hydrogel for the therapeutic treatment of aneurysms
AU698509B2 (en) Compositions for the treatment of rheumatoid-based arthritic diseases
AU3891299A (en) Combination therapy for treatment of depression
AU2001257903A1 (en) Method for treatment of neurodegenerative diseases
AU3596199A (en) Treatment of celiac disease
AU1772399A (en) Well treatment
AU3784999A (en) Methods for treatment of pain
AU2740899A (en) Treatment of liquids
AU1356201A (en) Treatment of hyperproliferative disorders
AU1697197A (en) Immunoconjugate for the treatment of aids
AU3896900A (en) Treatment of pain
AU4215499A (en) Treatment of neurodegenerative diseases
AU3596797A (en) Methods for the treatment of apolipoprotein e related diseases
AU7106300A (en) Treatment of skin disorders
AU1197599A (en) Detection of neurodegenerative diseases
AU3004000A (en) Methods for the treatment of apolipoprotein e related diseases
AU5854799A (en) Novel treatment of neurodegenerative diseases
AU1405001A (en) Treatment of diseases
AU2754997A (en) The treatment of plant diseases
EP1124555A4 (fr) Procede de traitement des maladies neurodegeneratives
AUPQ367699A0 (en) Treatment of cancer
AU5552400A (en) Treatment of cancer
AU2001262741A1 (en) Medicines for the prevention and treatment of neurodegenerative diseases
AUPP229598A0 (en) Treatment of sunburn
AU9082798A (en) Treatment of inflammatory conditions

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase